Associated Papers
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study.
Nelson BE et al.
Molecular Cancer, 2024
Evaluation of endocrine resistance using ESR1 genotyping of circulating tumor cells and plasma DNA.
Sundaresan TK et al.
Breast Cancer Research and Treatment, 2021
Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer.
Chung JH et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2017
Random mutagenesis of human estrogen receptor ligand binding domain identifies mutations that decrease sensitivity to estradiol and increase sensitivity to a diphenol indene-ol compound: basis for a regulatable expression system.
Miller N et al.
The Journal of Steroid Biochemistry and Molecular Biology, 1998
Select a paper to view details